301 Frequency and acceptance of CDSS-generated STOPP/START signals 15. Crowley EK, Sallevelt BTGM, Huibers CJA, Murphy KD, Spruit M, Shen Z, et al. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): A structured medication review with support of a computerised decision support system. BMC Health Serv Res 2020;20:1–12. https:// doi.org/10.1186/s12913-020-5056-3. 16. Prins MC, Drenth-Van Maanen AC, Kok RM, Jansen PAF. Use of a structured medication history to establish medication use at admission to an old age psychiatric clinic: A prospective observational study. CNS Drugs 2013;27:963–9. https://doi.org/10.1007/ s40263-013-0103-9. 17. Shen Z, Meulendijk M, Spruit M. A federated information architecture for multinational clinical trials: Stripa revisited. 24th Eur. Conf. Inf. Syst. ECIS 2016, 2016. 18. Barthel D, Mahoney F. Functional evaluation: The Barthel Index. Md State Med J 1965. 19. Damoiseaux-Volman BA, Medlock S, Raven K, Sent D, Romijn JA, van der Velde N, et al. Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study. Eur J Clin Pharmacol 2020. https:// doi.org/10.1007/s00228-020-03052-2. 20. Dalton K, O’Brien G, O’Mahony D, Byrne S. Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: A systematic review and meta-analysis. Age Ageing 2018;47:670–8. https://doi.org/10.1093/ageing/afy086. 21. O’Mahony D, Gudmundsson A, Soiza RL, Petrovic M, Jose Cruz-Jentoft A, Cherubini A, et al. Prevention of adverse drug reactions in hospitalized older patients with multimorbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing 2020;49:605–14. https://doi.org/10.1093/ageing/afaa072. 22. Dalton K, Curtin D, O’Mahony D, Byrne S. Computer-generated STOPP/START recommendations for hospitalised older adults: evaluation of the relationship between clinical relevance and rate of implementation in the SENATOR trial. Age Ageing 2020;49:615–21. https://doi.org/10.1093/ageing/afaa062. 23. Anrys P, Boland B, Degryse JM, De Lepeleire J, Petrovic M, Marien S, et al. STOPP/ START version 2-development of software applications: Easier said than done? Age Ageing 2016;45:590–3. https://doi.org/10.1093/ageing/afw114. 24. Sallevelt BTGM, Huibers CJA, Knol W, Puijenbroek E Van, Egberts T, Wilting I. Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: A quality appraisal study. BMJ Open 2020;10:1–8. https://doi.org/10.1136/ bmjopen-2019-033721. 25. Nauta KJ, Groenhof F, Schuling J, Hugtenburg JG, van Hout HPJ, Haaijer-Ruskamp FM, et al. Application of the STOPP/START criteria to a medical record database. Pharmacoepidemiol Drug Saf 2017;26:1242–7. https://doi.org/10.1002/pds.4283. 26. Himmel W, Kochen MM, Sorns U, Hummers-Pradier E. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther 2004. https://doi. org/10.5414/CPP42103. 27. Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: A cohort study. BMJ Open 2012. https://doi.org/10.1136/bmjopen-2012-001461. 28. Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: A randomized clinical trial. J Am Geriatr Soc 2014;62:1658–65. https://doi.org/10.1111/jgs.12993. 29. Mahony DO. 1044 Letters To the Editor May 2015–Vol. 63, No. 5 Jags 2015;63:223–4. 4
RkJQdWJsaXNoZXIy MTk4NDMw